Kristin Boggio
Pfizer (United States)(US)
Publications by Year
Research Areas
Genetics and Neurodevelopmental Disorders, Protein purification and stability, Advanced Proteomics Techniques and Applications, Pesticide Residue Analysis and Safety, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study(2021)41 cited
- → Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study(2022)15 cited
- → Additional file 2: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 1: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 5: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 9: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 6: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 10: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 8: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)
- → Additional file 3: of RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome(2017)